Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector.
Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector.
复制标题
DOI:
10.1016/j.virol.2014.10.035
复制
发表时间:
2015-01-15
期刊:
影响因子:
3.7
通讯作者:
van den Pol, Anthony N.
中科院分区:
文献类型:
--
作者:
Wollmann, Guido;Paglino, Justin C.;Maloney, Patrick R.;Ahmadi, Sebastian A.;van den Pol, Anthony N.
Vesicular stomatitis virus (VSV) shows promise as vaccine-vector and oncolytic virus. However, reports of neurotoxicity of VSV remain a concern. We compared 12 antiviral compounds to control infection of VSV-CT9-M51 and VSV-rp30 using murine and human brain cultures, and in vivo mouse models. Inhibition of replication, cytotoxicity and infectivity was strongest with ribavirin and IFN-α and to some extent with mycophenolic acid, chloroquine, and adenine 9-β-D-arabinofuranoside. To generate continuous IFN exposure, we made an adeno-associated virus vector expressing murine IFN; AAV-mIFN-β protected mouse brain cells from VSV, as did a combination of ribavirin and chloroquine. Intracranial AAV-mIFN-β protected the brain against VSV-CT9-M51. In SCID mice bearing human glioblastoma, AAV-mIFN-β moderately enhanced survival. VSV-CT9-M51 doubled median survival when administered after AAV-mIFN-β; some surviving mice showed complete tumor destruction. Together, these data suggest that AAV-IFN or IFN with ribavirin and chloroquine provide an optimal anti-virus combination against VSV in the brain.
登录
查看更多内容
影响因子:
5.4
作者:
COOMBS, K;MANN, E;BROWN, DT
通讯作者:
BROWN, DT
影响因子:
3.7
作者:
Johnson, J. Erik;Nasar, Farooq;Udem, Stephen A.
通讯作者:
Udem, Stephen A.
影响因子:
--
作者:
Jeulin, H.;Grancher, N.;Venard, V.
通讯作者:
Venard, V.
DOI:
10.1073/pnas.0602460103
发表时间:
2006-05-16
影响因子:
11.1
作者:
Delhaye, Sophie;Paul, Sophie;Michiels, Thomas
通讯作者:
Michiels, Thomas
影响因子:
12.4
作者:
Berraondo, P;Ochoa, L;Prieto, J
通讯作者:
Prieto, J